[1] Prentice K J, Saksi J, Hotamisligil G S. Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses[J]. J Lipid Res, 2019, 60(4): 734-740.[2] Zhou J, Deng Z, Chen Y, et al. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma[J]. Urol Oncol, 2015, 33(3): 113.e9-17.[3] Storch J, Mcdermott L. Structural and functional analysis of fatty acid-binding proteins[J]. J Lipid Res, 2009, 50 Suppl(Suppl): S126-31.[4] Hotamisligil G S, Bernlohr D A. Metabolic functions of FABPs--mechanisms and therapeutic implications[J]. Nat Rev Endocrinol, 2015, 11(10): 592-605.[5] Furuhashi M. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases[J]. J Atheroscler Thromb, 2019, 26(3): 216-232.[6] Ota H, Furuhashi M, Ishimura S, et al. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertensionand contributes to blood pressure elevation[J]. Am J Hypertens, 2012, 25(10): 1124-30.[7] Furuhashi M, Ishimura S, Ota H, et al. Lipid chaperones and metabolic inflammation[J]. Int J Inflam, 2011, 2011: 642612.[8] Damon M, Louveau I, Lefaucheur L, et al. Number of intramuscular adipocytes and fatty acid binding protein-4 content are significant indicators of intramuscular fat level in crossbred Large White x Duroc pigs[J]. J Anim Sci, 2006, 84(5): 1083-92.[9] Neuhouser M L, Aragaki A K, Prentice R L, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials[J]. JAMA Oncol, 2015, 1(5): 611-21.[10] Zeng J, Sauter E R, Li B. FABP4: A New Player in Obesity-Associated Breast Cancer[J]. Trends Mol Med, 2020, 26(5): 437-440.[11] Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin J J, et al. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention[J]. CA Cancer J Clin, 2017, 67(5): 378-397.[12] Hao J, Yan F, Zhang Y, et al. Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression[J]. Cancer Res, 2018, 78(9): 2343-2355.[13] Gyamfi J, Yeo J H, Kwon D, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer[J]. NPJ Breast Cancer, 2021, 7(1): 129.[14] Guaita-Esteruelas S, Bosquet A, Saavedra P, et al. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins[J]. Mol Carcinog, 2017, 56(1): 208-217.[15] Gharpure K M, Pradeep S, Sans M, et al. FABP4 as a key determinant of metastatic potential of ovarian cancer[J]. Nat Commun, 2018, 9(1): 2923.[16] 莫佳娅, 苏引利, 段浩然, et al. 脂肪酸结合蛋白 4 在卵巢癌中的表达及其对卵巢癌细胞上皮间充质转化的影响[J]. 河南医学研究, 2022, 31(14): 2501-2506.[17] Guo Y, Wang Z W, Su W H, et al. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma[J]. Biomed Res Int, 2020, 2020: 4145164.[18] 陈起跃. 胃癌侵袭转移中 FABP4 起抑癌基因作用及其分子机制研究[D]. 福建医科大学, 2020.[19] Sun N, Zhao X. Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer[J]. Front Pharmacol, 2022, 13: 948610.[20] Liu L, Mo M, Chen X, et al. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer[J]. J Exp Clin Cancer Res, 2023, 42(1): 85.[21] Li C, Zhang L, Qiu Z, et al. Key Molecules of Fatty Acid Metabolism in Gastric Cancer[J]. Biomolecules, 2022, 12(5).[22] Lee D, Wada K, Taniguchi Y, et al. Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinoma[J]. Oncol Rep, 2014, 31(3): 1116-20.[23] Tang Z, Shen Q, Xie H, et al. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)[J]. Oncotarget, 2016, 7(29): 46253-46262.[24] Luo Y, Yang Z, Li D, et al. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas[J]. Appl Immunohistochem Mol Morphol, 2017, 25(5): 351-357.[25] Huang M, Narita S, Inoue T, et al. Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production[J]. Oncotarget, 2017, 8(67): 111780-111794.[26] Li G, Wu Q, Gong L, et al. FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer[J]. Cancer Cell International, 2021, 21(1): 1-15.
